What is Proton Therapy
Read our Covid-19 policy

Call Now For More Information

General Questions or
Schedule an Appointment


Current Patients


Physician Line


Read our Covid-19 policy

Recruiting underway for a Clinical Trial

Recruiting underway for a Clinical Trial

The University of Washington, along with six other medical institutions in the United States, is recruiting candidates for the Phase II/III Randomized Trial of Intensity-Modulated Proton Beam Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for the treatment of oropharyngeal cancer of the head and neck. The trial will be open at SCCA Proton Therapy Center in the near future.

The goal of this clinical research study is to compare the side effects of two different radiation treatments for treatment of oropharyngeal cancer of the head and neck: IMRT and IMPT. IMPT uses beams of proton particles to send radiation directly to the tumor, whereas IMRT use photon (X-ray) beams. Both of these radiation treatments are designed to give radiation treatment to kill the tumor without harming the surrounding healthy tissue.

There are several inclusion and exclusion criteria for participation, but patients over 18 with documented squamous cell carcinoma of the oropharynx are invited to apply to see if they qualify. Participants may also receive chemotherapy along with radiation therapy, and can expect to contribute data to the study through August 2023.

To learn more about this study, interested candidates and their doctors may contact Jessica Dugal at the University of Washington. For more general information on clinical studies, please visit www.clinicaltrials.gov/ct2/about-studies/learn.